By continuing browsing this website, you accept the use of cookies to help us improve your user experience. Read more.

 Agrauxine fights against vinestock diseases

After extending the certification of the biofungicide Esquive WP to two other vinestock diseases (Esca and BDA) in France in 2014, Agrauxine has once again proven its expertise in vineyard protection by sponsoring the Advantage Project, the cost of which is estimated at €4.2M.

Agrauxine, sponsor of Advantage project

“The French wine-making industry suffers enormous losses due to vinestock diseases each year, totaling close to €1.5 billion in production losses and planting costs for wine-makers. This represents more than 10% of their net sales revenue, not to mention losses related to the impact of vinestock diseases on the quality of their wines,” explains Patricia Letousey, Biocontrol R&D Manager at Agrauxine. For this reason, in a context of increasing epidemics, the Advantage Project – which is supported by a French single interministerial fund (FUI) – is a very timely one, as it will be able to offer concrete solutions and tools based on imaging and modelling techniques in the next five to eight years.With its budget of €4.2M, one-third of which from public State/Regional funding (including from Pays-de-la-Loire), this project will rely on a consortium of nine industrial, technical and academic partners specialized in crop protection, the likes of Agrauxine, Bayer, Mercier Frères and the French Institute of Vine and Wine.